FibroGen (FGEN) Reports Q1 Loss, Tops Revenue Estimates

  • FibroGen (FGEN) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of $0.03. This compares to loss of $0.33 per share a year ago.